Table 4 Resistance rates of 27 strains to 10 antibiotics according to the different sites of infections among MDR-PA infected AP patients
From: The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients
Antimicrobial | Pancreas (n = 14) | Lung (n = 12) | Bloodstream (n = 1) | Total strains (n = 27) |
|---|---|---|---|---|
Amikacin | 2 (14.3) | 0 | 0 | 2 (7.4) |
Aztreonam | 10 (71.4) | 12 (100) | 1 (100) | 23 (85.2) |
Ciprofloxacin | 4 (28.6) | 7 (58.3) | 0 | 11 (40.7) |
Gentamicin | 3 (21.4) | 2 (16.7) | 0 | 5 (18.5) |
Imipenem | 5 (35.7) | 8 (66.7) | 1 (100) | 14 (51.9) |
Meropenem | 7 (50.0) | 8 (66.7) | 0 | 15 (55.6) |
Levofloxacin | 4 (28.6) | 6 (50.0) | 0 | 10 (37.0) |
Tobramycin | 1 (7.1) | 0 | 0 | 1 (3.7) |
Piperacillin-tazobactam | 4 (42.9) | 10 (83.3) | 0 | 16 (59.3) |
Macrodantin | 14 (100) | 12 (100) | 1 (100) | 27 (100) |